Physician video consultation
CORVIN advertises a secure physician consultation followed by individualized review of health history, goals, and laboratory results.
Provider source ↗Egg Harbor Township, NJ · Telehealth available
Provider overview
CORVIN Health Platform LLC publishes a telehealth practice with Richard Nussey as medical director and names APN and PA clinicians. The site displays an MD credential for Nussey, while the matched active CMS NPI record identifies Richard Nussey, DO, in New Jersey; this listing does not resolve that credential conflict. The official page enumerates 40 U.S. states plus Guam and the U.S. Virgin Islands, although separate headings claim 42 or 45 states, so only the 40 states explicitly named are encoded. The provider advertises investigational or unapproved compounds, whose names are preserved without adopting approval, sourcing, safety, or outcome claims.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Provider-advertised services, grouped for quick scanning with all details visible.
CORVIN advertises a secure physician consultation followed by individualized review of health history, goals, and laboratory results.
Provider source ↗The published workflow includes a blood panel ordered through a nearby Quest patient service center and reviewed by a physician.
Provider source ↗Sermorelin is listed as a provider-advertised option considered after physician evaluation and baseline laboratory review.
Provider source ↗The education section names BPC-157 and TB-500 for recovery-oriented protocols; these investigational compounds are recorded only as provider advertising.
Provider source ↗The provider discusses Epithalon and NAD+ within longevity-oriented care. The listing does not validate availability, approval, or outcome claims.
Provider source ↗Gonadorelin is named within the provider's hormone-oriented catalog and is considered only after an individualized consultation.
Provider source ↗DSIP is presented as a sleep-oriented compound discussed during consultation; its inclusion is not an approval or effectiveness statement.
Provider source ↗The site uses PT-141 and bremelanotide language for sexual-health care. This listing does not imply that every formulation or advertised use is FDA approved.
Provider source ↗Coverage and research
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Evidence
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity team and care model · Checked Aug 9, 2026
Supports: explicit states served · Checked Aug 9, 2026
Supports: services labs and compound catalog · Checked Aug 9, 2026
Supports: phone and location · Checked Aug 9, 2026
Supports: medical director npi and credential caveat · Checked Aug 9, 2026